Understanding Tricuspid Regurgitation Murmur

What is Tricuspid Regurgitation Murmur?

Tricuspid regurgitation (TR) is a condition in which the tricuspid valve – the valve located between the right atrium and right ventricle of the heart – does not close properly. When the valve leaks, blood flows backward (regurgitates) into the right atrium each time the right ventricle contracts. The turbulent flow creates a distinctive sound known as a tricuspid regurgitation murmur. This murmur is usually heard with a stethoscope over the lower left sternal border and often increases with inspiration (Carvallo’s sign).

TR can be primary (a problem with the valve itself) or secondary (caused by pressure or volume overload of the right heart). The murmur is an important clinical clue that prompts further evaluation for underlying heart disease.

Common Causes

Below are the most frequent conditions that lead to tricuspid regurgitation. Many patients have more than one contributing factor.

• Functional (secondary) TR – dilation of the right ventricle due to pulmonary hypertension, left‑sided heart failure, or chronic lung disease.
• Rheumatic heart disease – inflammation that damages the valve leaflets.
• Infective endocarditis – bacterial infection that destroys valve tissue.
• Congenital abnormalities – e.g., Ebstein anomaly, which displaces the tricuspid leaflets toward the apex.
• Trauma or iatrogenic injury – chest trauma, pacemaker leads, or previous cardiac surgery.
• Carcinoid syndrome – serotonin‑producing tumors cause fibrous plaque deposition on the valve.
• Degenerative (myxomatous) disease – same process that leads to mitral valve prolapse can affect the tricuspid valve.
• Right‑sided myocardial infarction – damage to the papillary muscles that support the valve.
• Pulmonary embolism – sudden rise in pulmonary artery pressure can acutely worsen TR.
• Severe chronic obstructive pulmonary disease (COPD) – chronic hypoxic vasoconstriction raises right‑ventricular afterload.

Associated Symptoms

Many patients with mild TR are asymptomatic, and the murmur may be the only finding. When regurgitation becomes moderate to severe, the following signs and symptoms often appear:

• Fatigue and reduced exercise tolerance.
• Swelling of the ankles, feet, or abdomen (peripheral edema, ascites).
• Abdominal fullness or discomfort due to liver congestion.
• Palpitations or irregular heartbeats (often from atrial fibrillation).
• Shortness of breath, especially on exertion.
• Jugular venous distention visible in the neck.
• Hepatomegaly (enlarged liver) and elevated liver enzymes.
• Cyanosis in advanced cases.

When to See a Doctor

Although a heart murmur alone is not an emergency, you should schedule an appointment if you experience any of the following:

• New or worsening shortness of breath.
• Unexplained swelling of the legs, ankles, or abdomen.
• Rapid, irregular, or pounding heartbeat.
• Chest discomfort, especially if radiating to the arm or jaw.
• Persistent fatigue that limits daily activities.
• Visible neck vein bulging (jugular venous distention).

Prompt evaluation helps determine whether the regurgitation is mild and benign or a sign of progressing heart disease that needs treatment.

Diagnosis

Diagnosing tricuspid regurgitation involves a stepwise approach that combines physical examination with imaging and, when needed, invasive testing.

1. Physical Examination

• Listen for a holosystolic, high‑pitched murmur best heard at the left lower sternal border.
• Ask the patient to breathe deeply; the murmur usually intensifies with inspiration (Carvallo’s sign).
• Assess for signs of right‑sided heart failure – peripheral edema, hepatomegaly, jugular venous distention.

2. Electrocardiogram (ECG)

Helps detect rhythm abnormalities (e.g., atrial fibrillation), right‑ventricular hypertrophy, or prior myocardial infarction.

3. Chest X‑ray

May show right‑ventricular enlargement, pulmonary artery hypertension, or concomitant left‑sided heart disease.

4. Echocardiography (Transthoracic – TTE)

The cornerstone test. It visualizes valve structure, quantifies the severity of regurgitation, measures right‑ventricular size and function, and evaluates pulmonary pressures. Colour‑Doppler helps grade TR as mild, moderate, or severe.

5. Transesophageal Echocardiography (TEE)

Used when TTE images are suboptimal, such as in obese patients or when detailed anatomy for surgery is required.

6. Cardiac Magnetic Resonance Imaging (CMR)

Provides precise measurement of right‑ventricular volumes and function, useful in complex cases or when surgical planning is needed.

7. Cardiac Catheterization

Reserved for patients with suspected pulmonary hypertension or when coronary artery disease must be ruled out before valve surgery.

Treatment Options

Treatment is tailored to severity, underlying cause, and the patient’s overall health.

Medical Management

• Diuretics (e.g., furosemide) – reduce volume overload and peripheral edema.
• ACE inhibitors/ARBs – lower systemic and pulmonary pressures in patients with left‑sided disease.
• Beta‑blockers – control heart rate in atrial fibrillation or tachycardia.
• Anticoagulation – indicated if atrial fibrillation or intracardiac thrombus is present.
• Pulmonary vasodilators (e.g., sildenafil) – for patients with significant pulmonary hypertension contributing to functional TR.
• Management of underlying disease – antibiotics for infective endocarditis, antiproliferative therapy for carcinoid syndrome, or disease‑modifying agents for COPD.

Interventional & Surgical Options

• Transcatheter Tricuspid Valve Repair (e.g., edge‑to‑edge Clip) – minimally invasive, suitable for high‑risk surgical patients.
• Tricuspid Valve Replacement (surgical) – mechanical or bioprosthetic valve; indicated for severe, symptomatic TR when repair is not feasible.
• Ring Annuloplasty – repairing the dilated annulus to improve leaflet coaptation.
• Combined Left‑ and Right‑sided valve surgery – often required when both mitral and tricuspid disease coexist.

Lifestyle & Home Care

• Limit sodium intake (<1500 mg/day) to lessen fluid retention.
• Maintain a healthy weight; obesity increases right‑ventricular workload.
• Engage in low‑impact aerobic exercise (e.g., walking, stationary cycling) as tolerated.
• Monitor daily weight; a sudden gain of >2 lb (≈1 kg) may signal fluid accumulation.
• Adhere to medication schedules and attend regular follow‑up appointments.

Prevention Tips

While you cannot prevent all causes of tricuspid regurgitation, you can reduce the risk of many contributing conditions:

• Control blood pressure and treat left‑sided heart disease early.
• Quit smoking and avoid exposure to second‑hand smoke – it lowers the risk of COPD and pulmonary hypertension.
• Manage chronic lung diseases with inhaled bronchodilators and steroids as prescribed.
• Maintain good oral hygiene and seek prompt treatment for infections to decrease endocarditis risk.
• For patients with known carcinoid tumors, follow oncologist‑directed therapy to limit serotonin exposure.
• Regular cardiovascular screening for people with a family history of valvular disease.

Emergency Warning Signs

If you notice any of the following, seek emergency medical care (call 911 or go to the nearest ER) immediately:

• Sudden, severe shortness of breath or difficulty breathing while at rest.
• Rapid, irregular heartbeat accompanied by dizziness, light‑headedness, or fainting.
• Chest pain that is crushing, squeezing, or radiates to the arm, neck, or jaw.
• Rapid swelling of the abdomen or a sudden increase in leg swelling.
• Blue discoloration of lips, fingers, or toes (cyanosis).

Key Take‑away

Tricuspid regurgitation murmur is a valuable clinical clue that may herald underlying right‑sided heart disease. Early recognition, appropriate diagnostic testing, and timely treatment—whether medical, lifestyle‑based, or surgical—can prevent progression to right‑heart failure and improve quality of life.

---

Sources: Mayo Clinic, American Heart Association, Cleveland Clinic, CDC, National Institute of Health (NIH), European Society of Cardiology Guidelines 2023, Journal of the American College of Cardiology 2022.